Loading …
Skip to content
BioBuzz BioBuzz

Biotech and Life Science News, Jobs, and Events for the BioHealth Capital Region

Primary Menu
  • Jobseeker
    • BioBuzz Featured Employers
      • American Gene Technologies
      • BioFactura
      • Kite
      • NextCure
    • Job Board
    • Biomanufacturing Jobs in Maryland
    • Career Resources
  • Employer
    • Become a Featured Employer
    • Post a Job
  • News
    • Newsletter
    • BioHealth Capital Region News
    • Philadelphia Biotech News
    • Capital Projects
    • Press Releases
  • Features
    • 5 Questions With…
    • In Conversation
    • People On The Move
    • Submit Your People On The Move
  • Events
    • Free Event Listing
  • Awards
    • 2021 Awards Winners
    • 2021 Awards Finalists
    • 2020 Awards Winners
    • 2020 Awards Finalists
  • Newsletter Subscribe

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal

Published on : November 23, 2020November 23, 2020 Published by : Chris Frew

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal

Tagged in : Acquisition COVID-19 Merck OncoImmune
Categorized in : BioHealth Capital Region News Featured
View All Jobs Post a Job

Past Newsletter Issues

Annual Sponsors

Bio-Trac
CRB
Frederick Department of Economic Development
  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • Youtube

CONTACT US ABOUT US

Terms & Conditions  Privacy Policy
Made with ♥ in Baltimore

© 2022 BioBuzz Media™